Announcements Trials
Browse Landscape

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Neoplasms 5Ovarian Neoplasms 3Lung Neoplasms 3Breast Neoplasms 3Prostatic Neoplasms 2Lymphoma 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Adenocarcinoma 2Urticaria 1Tuberous Sclerosis 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Severe Combined Immunodeficiency 1Salivary Gland Neoplasms 1Renal Insufficiency, Chronic 1Rectal Neoplasms 1Pancreatitis, Chronic 1Pancreatitis 1Pancreatic Cyst 1Non-alcoholic Fatty Liver Disease 1Neuroendocrine Tumors 1Neuroblastoma 1Nephritis 1Neoplasm Metastasis 1Multiple Sclerosis 1Mucopolysaccharidosis I 1Melanoma 1

Interventions

Blood Specimen Collection 6Radiotherapy 2Quality of Life 2Phlebotomy 2Interviews as Topic 2Drug Therapy 2zolbetuximab 1trastuzumab deruxtecan 1sargramostim 1pembrolizumab 1iopromide 1capecitabine-irinotecan combination 1X-Rays 1Tumor Burden 1Transurethral Resection of Prostate 1Tomography, X-Ray Computed 1Therapeutics 1Surveys and Questionnaires 1Risedronic Acid 1Registries 1Raloxifene Hydrochloride 1Radiofrequency Ablation 1Radiation, Ionizing 1Radiation 1Positron-Emission Tomography 1Patient Reported Outcome Measures 1Nivolumab 1Molecular Diagnostic Techniques 1Ipilimumab 1Induction Chemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Adenocarcinoma × Phlebotomy × Clear all
NCT00507702 2019-04-18

Identification of Key Blood Molecular Markers for Immunotherapy

Stanford University

Terminated
191 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Squamous Cell, Neoplasms

NCT00547742 2010-07-20

Correlation of PET-CT Studies With Serum Protein Analysis

Stanford University

Completed
1,500 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡